Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mozaffar

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Clinical Genetics|August 23, 2012
Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementiaS G Mehta, M Khare, R Ramani, et al.
Neurology|June 11, 2003
PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndromeM R Donaldson, J L Jensen, M Tristani-Firouzi, et al.
Neurology|August 5, 2011
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial designR G Miller, D H Moore, D A Forshew, et al.
Mitochondrion|December 15, 2007
Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategyS Bannwarth, V Procaccio, C Rouzier, et al.
Neurobiology of Disease|March 4, 2025
2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathyA Peck, A Dadi, Z Yavarow, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Clinical Genetics|August 23, 2012
Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementiaS G Mehta, M Khare, R Ramani, et al.
Neurology|June 11, 2003
PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndromeM R Donaldson, J L Jensen, M Tristani-Firouzi, et al.
Neurology|August 5, 2011
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial designR G Miller, D H Moore, D A Forshew, et al.
Mitochondrion|December 15, 2007
Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategyS Bannwarth, V Procaccio, C Rouzier, et al.
Neurobiology of Disease|March 4, 2025
2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathyA Peck, A Dadi, Z Yavarow, et al.
Pageof 3